StockData

Yarrow Bioscience, Inc. (YARW) stock

YARWNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 11/3089% above fair value
$12.90−1.33 (-9.35%)

Close on Nov 20, 2026Market cap $34.44MP/E –Yield –

Yarrow Bioscience pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Yarrow Bioscience's pe ratio was 0.6× on Apr 30, 2021, against 0.6× a year earlier.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2021Apr 30, 20210.6×−1.9
2020Dec 31, 20202.5×−2.2
2019Dec 31, 20194.6×–

More Yarrow Bioscience figures

See a number that looks wrong?